Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use ProgramMichael J. Satlin & Patricia J. Simner & Christine M. Slover & Yoshinori Yamano & Tsutae D. Nagata & Simon Portsmouth2023PDF883 KB
Clinical Outcomes and Emergence of Resistance of Pseudomonas Aeruginosa Infections Treated with Ceftolozane-tazobactam Versus Ceftazidime-avibactamDariusz A. Hareza & Sara E. Cosgrove & Robert A. Bonomo & Kathryn Dzintars & Sara M. Karaba & Armani M. Hawes & Tsigereda Tekle & Patricia J. Simner & Pranita D. Tamma2024PDF269 KB
